Cure My Disease

Don't miss your cure!

 Log in / Sign up

New french tool could better measure stroke recovery

NCT ID NCT07419087

Knowledge-focused Sponsor: Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is translating and testing a French version of the Trunk Impairment Scale (TIS), a tool that measures trunk control and balance while sitting. Researchers will enroll 67 stroke patients to check if the scale is accurate and reliable. The goal is to give French-speaking clinicians a validated way to assess recovery after a stroke.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide a reliable French-language tool for measuring trunk control and seated balance after a stroke.
What could go wrong
This is an observational validation study, not a treatment trial. It will not directly improve patient outcomes, and the scale may not perform as well in broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 67 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria (Phase 1): * Patients over 18 years of age * Patients who have had a stroke * Full understanding of the French language * No cognitive disorders * No prior exposure to the TIS scale * Covered by a social security system * Having been informed, having agreed to participate in the study, and having signed the free and informed consent form. Inclusion criteria (Phase 2): * Patients aged over 18 and under 85 years * Having had a stroke, with no time-since-onset limitation * Able to sit for 10 seconds without hand support * Able to provide informed consent * With an NIHSS score between 2 and 26 * Covered by a social security system * Having been informed, having agreed to participate in the study, and having signed the free and informed consent form Exclusion Criteria (Phase 1): * Insufficient command of the French language * Inability to understand instructions * Persons deprived of liberty (by judicial or administrative decision) * Adults under legal protection or unable to express their consent * Pregnant or breastfeeding women Exclusion Criteria (Phase 2): * Contraindication to the sitting position or to hip adduction (hip prosthesis) * History of orthopedic or neurological disorders affecting sitting balance * Insufficient command of the French language * Inability to understand instructions * Person deprived of liberty (by judicial or administrative decision) * Adult under legal protection or unable to express consent * Pregnant or breastfeeding woman

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke (CVA) or tia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder transient ischemic attack

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke (CVA) or tia Stroke (CVA) or transient ischemic attack

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre de Kerpape

    RECRUITING

    Ploemeur, Please Choose..., 56270, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.